Loomis, Sayles and »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Loomis, Sayles and

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Loomis, Sayles and from 13F filings

Historical chart of Loomis, Sayles and investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Loomis, Sayles and consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Loomis, Sayles and

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 15k 129.44

More positions owned by Loomis, Sayles and

Nvidia Corp Common (NVDA)
Meta Platforms Common (META)
Amazon.com Common (AMZN)
Visa Inc-class A Shrs Common (V)
Alphabet Inc-cl A Common (GOOGL)
Microsoft Corp Common (MSFT)
Netflix.com Common (NFLX)
Boeing Common (BA)
Tesla Common (TSLA)
Oracle Corp Common (ORCL)
Salesforce.com Common (CRM)
The Walt Disney Common (DIS)
Autodesk Common (ADSK)
Monster Beverage Corporation Common (MNST)
Vertex Pharmaceuticals Common (VRTX)

View all positions for Loomis, Sayles and

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
BlackRock
Braidwell
Lazard Asset Management
Davidson Kempner Capital Management
Readystate Asset Management
Citadel Advisors
Steelhead Partners
Bank of America Corporation
D. E. Shaw & Co
Tenor Capital Management
Bank Of Montreal
FMR
Nuveen Asset Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1